BGI, a leading provider of genomic sequencing and proteomic services, will be attending the American Society for Mass Spectrometry (ASMS) Annual Conference from June 5 to June 9 in Minneapolis (Minnesota, USA) where the company will present its multi-omics mass spectrometry service portfolios and novel research in proteomics.

Stop by booth 403 to learn about our multiomics solutions for your projects. Also, enter a raffle to win a prize! Our booth is very close to the entrance of the exhibit hall.

BGI offers one of the industry's most comprehensive multiomics mass spec service portfolios with excellent data quality and quick turnaround time. We transform research and accelerate drug discovery through the following applications and more:

Meet Billy Newton, our lab scientist in a poster session to learn about our novel research in proteomics:  

(Abstract WP 458) Phosphoproteome is a key component to some biological pathways. Being able to accurately quantify a phosphoproteomic experiment advantage the possibility to uncover unknown mechanistic biology. Data Independent Acquisition (DIA) is a powerful tool for phosphoproteomic quantification. Here, we demonstrated a DIA based phosphoproteome quantitation comparison between two state-of-art ion mobility equipped instruments: the timsTOF Pro2 and FAIMS Pro Eclipse. Different internal designs and acquisition strategies of the two instruments warranted a performance comparison using the same input material and instrument time. To achieve in-depth phosphoprotome coverage, two orthogonal fractionation methods were used. Both instruments and their DIA methodologies were compared in multiple dimensions including identification and quantification numbers, consistency between replicates and accuracy as well as sensitivity of the spike-in samples.